Skip to main content

Table 1 Routine statistics of ledger books: average monthly number of patients positive by m RDT, and ALu blisters & quinine vials issued by the main store, before and after m RDT implementation, in intervention and control health facilities.

From: Reduction of anti-malarial consumption after rapid diagnostic tests implementation in Dar es Salaam: a before-after and cluster randomized controlled study

Health facility Patients positive bymRDT
Number per
monthn
ALu blisters £ Quinine vials &
   Before m RDT initiation*
Blisters per
month
n
After m RDT initiation#
Blistersper
month
n
Post-intervention blisters
as a proportion of
pre-intervention
PP (95% CI)
Before m RDT initiation$
Vialsper
month
n
After m RDT initiation#
Vialsper
month
n
Post-intervention vials
as a proportion of
pre-intervention
PP (95% CI)
Intervention health facilities       
Hospital 1 495 4560 1326 0.29 3205 1503 0.47
Hospital 2 323 1500 307 0.20 5049 549 0.11
Hospital 3 335 3100 1608 0.52 1747 1048 0.60
Health centre 1 329 3000 1890 0.63 830 272 0.33
Health centre 2 209 1430 268 0.19 553 86 0.16
Health centre 3 93 1540 360 0.23 177 92 0.52
Dispensary 1 43 650 25 0.04 59 26 0.44
Dispensary 2 101 770 202 0.26 245 85 0.35
Dispensary 3 210 4110 1947 0.47 303 111 0.37
Total of 9 HFŦ     0.32 (0.20 - 0.43)    0.37 (0.28 - 0.46)
Total of 6 matched intervention HFŦ 0.30 (0.15 - 0.46)    0.36 (0.24 - 0.48)
Control health facilities       
Control 1 N.A 1900 1952 1.03 280 766 2.73
Control 2 N.A 3410 1353 0.40 209 151 0.72
Control 3 N.A 4180 2617 0.63 217 871 4.01
Total of 3 matched control HFŦ   0.68 (0.46 - 0.91)    2.49 (1.62 - 3.35)
  1. £ One blister of ALU is needed for one anti-malarial course, whatever the age or weight of the patient, &Between 2 and 6 vials are used per anti-malarial course, * observation period of only 3 months because ALu only introduced in Tanzania in January 2007, # observation period of 18 months, $ observation period of 15 months, Ŧ allowing for random-effect.